ABSTRACT
Introduction
Chest pain constitutes the 50% of the symptoms resulting in an emergency admittance and 25% of the admitting patients are internalized 1 . Frequently, the chest pain is the unique symptom of the acute coronary syndrome. In a study evaluating the outcomes of the patients admitted to the emergency department with chest pain, the rates of the fi nal diagnoses of AMI, unstable angina pectoris (USAP) and non cardiac chest pain were 1/3, 1/3 and 1/3, respectively 2 .
Acute coronary syndrome may manifest with a series of clinical syndromes including ST segment elevation Myocardial infarction (STEMI), NON ST elevation myocardial infarction (NSTEMI) and USAP. These life threatening clinical syndromes are serious and should be diagnosed and treated immediately 3, 4 .
All around the world AMI is the leading cause of death. In western countries half of the deaths are due to the cardiovascular diseases and 75% of them are related to coronary artery diseases 5 .
In one-third of the AMIs, there is not a clinical symptom. Electrocardiographic examination fails in diagnosis during the fi rst attendance 3, 4 . Uncertainty and delays in diagnosis lead to the improper management options and may delay initiation of life-saving treatments.
In 2000, European Society of Cardiology (ESC) and American College of Cardiology (ACC) redefi ned AMI. According to both societies, AMI is diagnosed in case when CPK-MB and/or Troponin-I (TN-I) level(s) elevations are associated with the concordant symptoms or ECG alterations.
The routine use of modern biomarkers signifi cantly enabled the evaluation of myocardial damage. Following the use of new markers, 1/3 of patients who had previously diagnosed with USAP were revaluated as having a "myocardial damage" 6 .
Heart type free fatty acid binding protein (H-FABP) is a recently discovered cardiac biomarker. It is a low molecular weight (LMW= 15-16 kDa) cytosolic protein specifi c to cadiomyocyte and plays an important role in the intracellular-transport of the fatty acids for ß-oxidation in mitochondrias 7, 8 . H-FABP refl ects the sarcolemmal change during acute myocardial ischemia. Plasma kinetics and secretion of H-FABF is similar to myoglobin, thus it is valuated as a marker in the early diagnosis of AMI (in the fi rst 2 hours) 9 . There are remarkable numbers of studies for the valuation of H-FABP in NSTEMI, but only a few in STEMI.
High myocardial tissue content, intra-cytosolic domination, low molecular weight, relative tissue specifi city and early demonstrability in urine and blood after the initiation of AMI (within the fi rst two hours) construct the rationality for the use of H-FABP in the early diagnosis of acute coronary syndrome 10 . H-FABP concentration in myocardial muscle is higher than in skeletal muscle in comparison to myoglobin. In addition its basal concentration is lower than the basal concentration of myoglobin. This feature makes H-FABP superior to myoglobin for diagnostic use [11] [12] [13] .
In this study we aimed to evaluate the diagnostic effectiveness of H-FABF in the early diagnosis of the acute coronary syndrome in comparison to CPK-MB and Troponin-I.
Methods
This prospective study was performed in Haseki Research and Education Hospital of Turkish Ministry of Health. During patient care, clinical evaluation and performing the study we obeyed the statement of Helsinki Declaration.
The study group included 41 patients diagnosed with acute coronary syndrome regarding to the specifi c ECG changes, demonstration of the cardiac markers and chest pain with an onset within the last 12 hours before admission to the emergency unit of the hospital. The control group included 38 patients with a symptom of chest pain of non cardiac origin. The non cardiac origin of the chest pain was considered regarding to the continuous normal ECG fi ndings and cardiac marker levels.
Patients younger than 15, and admitted to hospital and treated within the last one week with a symptom of chest pain were excluded. Renal failure, previous angiography-by pass-stent or open heart surgery, depression or somatization disorder, chronic obstructive pulmonary disease, cerebro-vascular accident (recent or current), acute mesenteric artery disease, multi organ failure, serious hemodynamic disturbances and unwillingness to participate in the study also caused exclusion.
Data including the demographics and past medical history such as age, gender, systemic diseases, coronary risk factors and routine use of medications were recorded. All participants were evaluated by using ECG tracings, and the serum levels of cardiac enzymes, lipids and the basic routine biochemical parameters.
H-FABP levels were measured by using Hycult biotech HK 401 Human H-FABP Elisa kits and the sandwich method. CPK-MB and Troponin-I levels were measured in Liaison Diasorin apareil with the principle of chemiluminescent microparticle immunoassay. The study groups were compared by using the recorded data and the serum H-FABP levels.
Coronary artery risk factors were isolated according to the 3rd adult treatment panel (ATP III) of National Cholesterol Education Program (NCEP) and the Turkish Society of Cardiology's coronary heart disease prevention and treatment guide. SPSS version 14.0 statistical package program for windows was used for statistical analysis. During the comparison of the study and control groups, Student t test was used for continuous variables with normal distribution. Between group categorical variables or variables with non normal distribution were analyzed by using Mann Whitney or chi-square (or Fischer's) tests, appropriately. A ROC curve analysis was performed to defi ne the sensitivity and specifi city of the measurement of the H-FABP levels to diagnose the acute coronary syndrome. The specifi city and sensitivity of H-FABP, CPK-MB and Troponin-I were evaluated for the time intervals depending on the onset of the symptoms as between 0-4, 4-12 and 0-12 hours by using the analysis of area under the curve (AUC). A p value of <0.05 was considered signifi cant.
Results
The data dealing with the parameters of gender, age, and smoking did not differ between the study and the control groups with p values of 0.732, 0.299 and 0.082, respectively (p>0.05).
The symptoms during hospital admission were not signifi cantly different between groups (p>0.05), however hypertension and hyperlipidemia were more frequent in the study group (p<0.05). Other than the more frequent use of ß-blockers in the study group (p<0.05), previously used medications (Table 1) were not signifi cantly different in both groups (p>0.05). Area under the curve was measured larger for H-FABP at all studied time intervals (Graph 1-3) in comparison with the AUC measured for CPK-MB and Troponin-I (p<0.05). Table 2 summarizes the achieved values for the AUC analysis of the three markers.
Discussion
Depending to the fi ndings of our study H-FABP with high sensitivity and specifi city rates is a useful marker for the earlier diagnosis of acute coronary syndrome and the routine use of it may increase the rates of early diagnosis.
H-FABP measurements in the evaluation of patients admitted to the emergency units with a symptom of chest pain are not well studied. In this manner our study may aid in the collection of the data dealing with the issue. However, our study refl ects results of a single center and the validation of the H-FABP is based on the clinical evaluation of the acute coronary syndrome. In addition, the sensitivity and the specifi city analysis were based on the clinical diagnosis which was also affected by the measurements of the other markers, CKP-MB and Troponin-I. More objective diagnostic tools such as myocardial scintigraphy and angiography are lacking in our study.
Our study is not a randomized study and the absence of a power analysis necessitates further randomized studies including larger series.
Acute myocardial infarction as the major cause of death is frequently associated with hypertension and hyperlipemia 10, [14] [15] [16] [17] [18] . Similarly, in our study patients diagnosed with acute coronary syndrome had signifi cant associations with hypertension (n= 26, 63%) and hyperlipemia (n= 25, 61%).
Although it has not taken its place in routine clinical management of acute myocardial infarction yet, its adjunction to the routinely used cardiac markers may present H-FABP as a new cardiac marker in the early diagnosis of acute myocardial infarction 19 . It is a cytoplasmic protein derived from the damaged 24 found that the sensitivity of CPK-MB was higher than the sensitivity of Troponin-I in the fi rst 2 to 5 hours of cardiac damage. In our study, in the fi rst 0-4 hours, the sensitivity and the specifi city of H-FABP were 99% and 99%, respectively. The sensitivity and the specifi city rates in the same patient group for CPK-MB were 70.59% and 89.66%, respectively. Seino et al. 25 found the sensitivity of H-FABP 89% in the fi rst 2 hours of the myocardial infarction. AUC analysis of the H-FABP in 0-4 hours of our study revealed a larger area (s=0.997) which may be resulted from studying a longer time period after the onset of the symptoms.
The sensitivity and specifi city of H-FABP, CPK-MB and Troponin-I were 97.6 and 88.5%, 97.6 and 88.5%, and 100% and 88.5% in the study performed by Cavus et al 19 , respectively. In our study the sensitivity and specifi city of H-FABP, CPK-MB and Troponin-I between the 4 th and 8 th hours of acute myocardial infarction were 100 and 99%, 70.8 and 100%, and 100 and 100%, respectively.
The discordance among the results of the previous studies and the current study may originate from the variable methodology and patient population encountered in the studies. Although the quality of the evidences provided from these studies seems poor, they provide a clue for further studies. Further randomized studies are needed to evaluate the exact role of H-FABP in the diagnosis of acute myocardial infarction.
In conclusion H-FABP may be detected in the blood samples of patients diagnosed with acute coronary syndrome by using the appropriate and sensitive laboratory testing methods and it may be used as an alternative diagnostic tool instead of the traditional markers.
